XPO250117C145000
- 2.75
- +1.15+71.88%
XPO Newsroom
TD Cowen Maintains XPO(XPO.US) With Buy Rating, Maintains Target Price $150
Wells Fargo Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $175
Goldman Sachs Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $167
Goldman Sachs Maintains Buy on XPO, Raises Price Target to $167
Oppenheimer Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $176
XPO Analyst Ratings
Barclays Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $170
J.P. Morgan Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $160
XPO Is Maintained at Overweight by JP Morgan
BMO Capital Maintains XPO(XPO.US) With Buy Rating
Citi Maintains XPO(XPO.US) With Buy Rating, Maintains Target Price $179
BofA Securities Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $171
XPO Analyst Ratings
Stephens & Co. Reiterates Overweight on XPO, Maintains $165 Price Target
Barclays Maintains XPO(XPO.US) With Buy Rating, Maintains Target Price $170
Barclays Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $170
XPO Analyst Ratings
Citi Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $179
TD Cowen Maintains XPO(XPO.US) With Buy Rating, Maintains Target Price $150
Stifel Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $131